Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NNC0142-0002 in Active Rheumatoid Arthritis
NCT01181050Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Aug 2010
- Primary completion
- Apr 2012
- Modality
- Monoclonal Antibodies
- Countries
- 3
01
Overview
A Phase 2 trial of NNC0142-0002 in rheumatoid arthritis (RA), sponsored by Janssen Pharmaceutical. Started Aug 2010; status: completed.
02
Drugs
NNC0142-0002
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01181050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01181050.